With two key focus areas, In Vitro Modelling and Early Stage Drug Candidates, Bioneer helps develop and produce your promising early drug candidates from as early on as their inception, and we generate key early insights into their mechanisms, efficacy and safety.
Bioneer has vast experience in developing advanced in vitro models and assays which can mirror cellular or molecular aspects of diseases and in vivo conditions. We are specialists in developing CNS, immune and cancer models and models within the gastro-intestinal field.
Our Early Stage Drug Candidate program helps you get from your idea to your first protein and product. We are experts in all aspects of expression, purification, characterization, formulation and small-scale non-GMP manufacturing of recombinant proteins.
Our formulation development covers recombinant proteins, peptides and small molecules and assist companies in their earliest phases producing drug candidate.
We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.